Cite
MLA Citation
Wenfeng Fang et al.. “Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.” Lancet oncology, vol. 19, no. 10, 2018, pp. 1338–1350. http://access.bl.uk/ark:/81055/vdc_100070083059.0x000016